"label","id","instanceType","name","text","description","uuid:ID"
"","Objective_1","Objective","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","bfdf3125-e41d-4419-aa0e-909f7f8e35c7"
"","Objective_2","Objective","OBJ2","To document the safety profile of the xanomeline TTS.","Safety","ae65887a-36f3-4d49-9167-342bd56c03a8"
"","Objective_3","Objective","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","4a7dd91a-ce77-4174-a459-051c23f13c2c"
